Glycemic Control Clinical Trial
Official title:
Short-term Effects of Dapagliflozin on Fasting and Postprandial Glucose Homeostasis in Male Type 1 Diabetes Patients.
Dapagliflozin is a highly selective, reversible and potent inhibitor of the sodium-glucose-linked Transporter 2 (SGLT2), which was successfully investigated for its use as a treatment option in type 2 diabetes mellitus. The effect of dapagliflozin is an increased glucosuria, and it was shown that mean blood glucose concentrations and postprandial glucose excursion in special were significantly reduced in type 2 diabetic patients. Due to its mechanism-of action it seems likely that also type 1 diabetic patients will benefit from dapagliflozin. The present study is focused on the effects of dapagliflozin on fasting glucose homeostasis and postprandial glucose excursion in male type 1diabetic patients. Participants will subsequently receive 10 milligrams of dapagliflozin and placebo for 3 days (equals 2 x 30mg per cross-over period) in a double-blind, randomised, cross-over design. The effects will be measured via euglycemic hyperinsulinemic clamp studies (fasting glucose homeostasis) and euglycemic oral glucose tolerance clamp tests (postprandial glucose excursions).
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT06309654 -
Home-Based Circuit Training in Overweight/Obese Older Adult Patients With Knee Osteoarthritis and Type 2 Diabetes
|
N/A | |
| Active, not recruiting |
NCT05460884 -
Effects of Seaweed Extract on Postprandial Response to White Bread
|
N/A | |
| Completed |
NCT00576394 -
Aggressive Versus Moderate Glycemic Control in Diabetic Coronary Bypass Patients
|
Phase 1 | |
| Recruiting |
NCT05777746 -
The Effect of an Online Plant-Based Dietary Program on Cardiovascular Risk Factors in Persons With Type 2 Diabetes Mellitus: A Randomized Controlled Trial
|
N/A | |
| Completed |
NCT00898534 -
Effect of Immediate Hemoglobin A1c on Glycemic Control in Children With Type I Diabetes Mellitus
|
Phase 4 | |
| Recruiting |
NCT05115682 -
Circadian Rhythm and Metabolic Effects of Exercise
|
N/A | |
| Completed |
NCT04994327 -
Bread Replacement - Facing the Challenge to Improve Its Quality for Better Metabolic Health
|
N/A | |
| Terminated |
NCT01549964 -
Comparison of TAK-875 to Placebo and Sitagliptin in Combination With Metformin in Participants With Type 2 Diabetes
|
Phase 3 | |
| Recruiting |
NCT04332393 -
Metformin to Treat Corticosteroids-induced Hyperglycemia
|
Phase 4 | |
| Recruiting |
NCT04821752 -
Environmental Toxicants Avoidance Study
|
N/A | |
| Completed |
NCT06217679 -
Comparing the Effects of Different Types of Exercise on Glucose Handling
|
N/A | |
| Completed |
NCT00821665 -
Blood Glucose Homeostasis in Type 2 Diabetes: the Effects of Saccharose
|
N/A | |
| Terminated |
NCT04171648 -
Effect of Dry Roasted Peanuts and Boiled Peanuts on Glycemic Control
|
N/A | |
| Completed |
NCT05279183 -
Assessment of Reward Responses to Erythritol Using Flavor Preference Learning
|
N/A | |
| Completed |
NCT05166200 -
Glycemic Response in Adults With Type 2 Diabetes
|
N/A | |
| Not yet recruiting |
NCT05644717 -
Effect of Erugliflozin On Liver Fat, Liver Fibrosis and Glycemic Control in Type II DM Patients With NASH/NAFLD
|
Phase 4 | |
| Active, not recruiting |
NCT00283972 -
LAP-BAND Observational Cohort
|
Phase 4 | |
| Completed |
NCT00460499 -
Improving Outcomes In Diabetic Patients During CABG Surgery By Optimizing Glycemic Control
|
Phase 1 | |
| Completed |
NCT00848315 -
Diabetes Management in Low-Income Hispanic Patients
|
Phase 2 | |
| Completed |
NCT03983499 -
Latinos Understanding the Need for Adherence in Diabetes
|
N/A |